News

NeuroEM Therapeutics(R) Closes Initial Rounds in $5 Million Equity Raise to Commercialize Drug-free Alzheimer’s Treatment
TAMPA, FL / ACCESS Newswire / June 13, 2025 / NeuroEM Therapeutics®, an award-winning clinical-stage biotechnology research ...
AZ Central3d
Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59 at Increased Risk for RSV Disease
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and ...
Detroit Free Press2d
NeuroEM Therapeutics(R) Closes Initial Rounds in $5 Million Equity Raise to Commercialize Drug-free Alzheimer’s Treatment
“We’re proud to support the advancement of this groundbreaking technology, and I’m personally honored to help guide NeuroEM as it brings innovative, non-invasive therapies to the forefront ...